Skip to main content

Table 2 Effect of silymarin on serum and liver lipid profile

From: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

Group

Lipid Profile of Rats

LDL-C (mg/dl)

TC (mg/dl)

HDL-C (mg/dl)

S-TG (mg/dl)

H-TG (mmol/g)

NC

5.50 ± 2.43

39.00 ± 4.77

17.00 ± 2.28

39.17 ± 5.52

0.5 ± 0.01

FC

9.00 ± 2.37*

53.83 ± 7.91*

12.17 ± 3.54

57.83 ± 8.10**

0.57 ± 0.03***

SC

6.00 ± 1.79

42.50 ± 6.95

15.83 ± 3.31

42.83 ± 6.05 ##

0.52 ± 0.01 ###

FTH

6.83 ± 1.94

50.67 ± 7.89

12.67 ± 3.08

45.50 ± 9.65 #

0.54 ± 0.02 #

FFH

6.67 ± 1.21

48.50 ± 10.84

15.33 ± 2.58

44.17 ± 4.96 #

0.53 ± 0.02 #

  1. At the end of the experiment serum and liver lipid profile were measured. NC normal control, FC fructose control, SC silymarin control, FTH fructose + 200 mg/kg silymarin, FFH fructose + 400 mg/kg silymarin. Data were presented as mean ± SD. N = 6 for each group. * p < 0.05 vs. NC; ** p < 0.01 vs. NC; *** p < 0.001 vs. NC and # p < 0.05 vs. FC; ## p < 0.01 vs. FC; ### p < 0.001 vs. FC
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us